Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't ...
AZoLifeSciences on MSN
Machine learning model accelerates manufacturing timeline of monoclonal antibodies
As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.
In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & ...
naturopathic medicine, functional medicine, integrative medicine, thymosin alpha-1, immunosenescence, thymic involution, inflammaging, peptide therapy ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
Five years ago, during 2020 Battery Day, Tesla unveiled the 4680 cells as the most advanced battery tech in the world. However, CEO Elon Musk now regrets he pursued the dry battery electrode process, ...
A research team at the Max Planck Institute for Chemical Ecology has successfully combined single-cell RNA sequencing (scRNA-seq) and single-cell mass spectrometry (scMS) analysis on the same plant ...
Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...
DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...
Real-time batch monitoring powered by machine learning is helping manufacturers detect deviations early to reduce failures, improve consistency and cut costs. By simulating cell and gene therapy ...
Intel is reportedly still struggling with a chipmaking process crucial to its future. Reuters reports that the company's 18A process is still producing low yields and high defect rates. Intel has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results